{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:25:46Z","timestamp":1790983546478,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pendrin is a Cl<jats:sup>\u2212<\/jats:sup>\/HCO<jats:sub>3<\/jats:sub><jats:sup>\u2212<\/jats:sup> exchanger selectively present in the intercalated cells of the kidney. Although experimental studies have demonstrated that pendrin regulates blood pressure downstream of the renin-angiotensin-aldosterone system, its role in human hypertension remains unclear. Here, we analyzed the quantitative changes in pendrin in urinary extracellular vesicles (uEVs) isolated from a total of 30 patients with primary aldosteronism (PA) and from a rat model of aldosterone excess. Western blot analysis revealed that pendrin is present in dimeric and monomeric forms in uEVs in humans and rats. In a rodent model that received continuous infusion of aldosterone with or without concomitant administration of the selective mineralocorticoid receptor (MR) antagonist esaxerenone, pendrin levels in uEVs, as well as those of epithelial Na<jats:sup>+<\/jats:sup> channel (ENaC) and Na-Cl-cotransporter (NCC), were highly correlated with renal abundance. In patients with PA, pendrin levels in uEVs were reduced by 49% from baseline by adrenalectomy or pharmacological MR blockade. Correlation analysis revealed that the magnitude of pendrin reduction after treatment significantly correlated with the baseline aldosterone-renin ratio (ARR). Finally, a cross-sectional analysis of patients with PA confirmed a significant correlation between the ARR and pendrin levels in uEVs. These data are consistent with experimental studies showing the role of pendrin in aldosterone excess and suggest that pendrin abundance is attenuated by therapeutic interventions in human PA. Our study also indicates that pendrin analysis in uEVs, along with other proteins, can be useful to understand the pathophysiology of hypertensive disorders.<\/jats:p>","DOI":"10.1038\/s41440-021-00710-5","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T09:02:43Z","timestamp":1627549363000},"page":"1557-1567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Characterization of pendrin in urinary extracellular vesicles in a rat model of aldosterone excess and in human primary aldosteronism"],"prefix":"10.1038","volume":"44","author":[{"given":"Fumika","family":"Ochiai-Homma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Kuribayashi-Okuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Tsurutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Ishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Odajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Kawagoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Tomomitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Murakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Asakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daigoro","family":"Hirohama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michito","family":"Nagura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifuru","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Fujigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"710_CR1","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293\u20132300.","journal-title":"J Am Coll Cardiol"},{"key":"710_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1291\/hypres.27.193","volume":"27","author":"M Omura","year":"2004","unstructured":"Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004;27:193\u2013202.","journal-title":"Hypertens Res."},{"key":"710_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, et al. Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension. 2006;48:232\u20138.","journal-title":"Hypertension."},{"key":"710_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41440-018-0158-6","volume":"42","author":"A Nishiyama","year":"2019","unstructured":"Nishiyama A. Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease. Hypertens Res. 2019;42:293\u2013300.","journal-title":"Hypertens Res."},{"key":"710_CR5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41440-020-0468-3","volume":"43","author":"S Morimoto","year":"2020","unstructured":"Morimoto S, Ichihara A. Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension. Hypertens Res. 2020;43:744\u201353.","journal-title":"Hypertens Res."},{"key":"710_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2215\/CJN.05760513","volume":"10","author":"D Pearce","year":"2015","unstructured":"Pearce D, Soundararajan R, Trimpert C, Kashlan OB, Deen PM, Kohan DE. Collecting duct principal cell transport processes and their regulation. Clin J Am Soc Nephrol. 2015;10:135\u201346.","journal-title":"Clin J Am Soc Nephrol."},{"key":"710_CR7","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1152\/physrev.00011.2019","volume":"100","author":"SM Wall","year":"2020","unstructured":"Wall SM, Verlander JW, Romero CA. The renal physiology of pendrin-positive intercalated cells. Physiol Rev. 2020;100:1119\u201347.","journal-title":"Physiol Rev."},{"key":"710_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1152\/physrev.00044.2018","volume":"100","author":"EJ Hoorn","year":"2020","unstructured":"Hoorn EJ, Gritter M, Cuevas CA, Fenton RA. Regulation of the renal NaCl cotransporter and its role in potassium homeostasis. Physiol Rev. 2020;100:321\u201356.","journal-title":"Physiol Rev."},{"key":"710_CR9","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1161\/01.HYP.0000145863.96091.89","volume":"44","author":"SM Wall","year":"2004","unstructured":"Wall SM, Kim YH, Stanley L, Glapion DM, Everett LA, Green ED, et al. NaCl restriction upregulates renal Slc26a4 through subcellular redistribution: role in Cl- conservation. Hypertension. 2004;44:982\u20137.","journal-title":"Hypertension."},{"key":"710_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1681\/ASN.2017030243","volume":"29","author":"D Hirohama","year":"2018","unstructured":"Hirohama D, Ayuzawa N, Ueda K, Nishimoto M, Kawarazaki W, Watanabe A, et al. Aldosterone is essential for angiotensin ii-induced upregulation of pendrin. J Am Soc Nephrol. 2018;29:57\u201368.","journal-title":"J Am Soc Nephrol"},{"key":"710_CR11","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1161\/01.HYP.0000088321.67254.B7","volume":"42","author":"JW Verlander","year":"2003","unstructured":"Verlander JW, Hassell KA, Royaux IE, Glapion DM, Wang ME, Everett LA, et al. Deoxycorticosterone upregulates PDS (Slc26a4) in mouse kidney: role of pendrin in mineralocorticoid-induced hypertension. Hypertension. 2003;42:356\u201362.","journal-title":"Hypertension."},{"key":"710_CR12","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1681\/ASN.2012080787","volume":"24","author":"T Jacques","year":"2013","unstructured":"Jacques T, Picard N, Miller RL, Riemondy KA, Houillier P, Sohet F, et al. Overexpression of pendrin in intercalated cells produces chloride-sensitive hypertension. J Am Soc Nephrol. 2013;24:1104\u201313.","journal-title":"J Am Soc Nephrol"},{"key":"710_CR13","doi-asserted-by":"publisher","first-page":"13368","DOI":"10.1073\/pnas.1202671109","volume":"109","author":"M Soleimani","year":"2012","unstructured":"Soleimani M, Barone S, Xu J, Shull GE, Siddiqui F, Zahedi K, et al. Double knockout of pendrin and Na-Cl cotransporter (NCC) causes severe salt wasting, volume depletion, and renal failure. Proc Natl Acad Sci USA. 2012;109:13368\u201373.","journal-title":"Proc Natl Acad Sci USA."},{"key":"710_CR14","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1046\/j.1523-1755.2002.00671.x","volume":"62","author":"CA Wagner","year":"2002","unstructured":"Wagner CA, Finberg KE, Stehberger PA, Lifton RP, Giebisch GH, Aronson PS, et al. Regulation of the expression of the Cl-\/anion exchanger pendrin in mouse kidney by acid-base status. Kidney Int. 2002;62:2109\u201317.","journal-title":"Kidney Int."},{"key":"710_CR15","doi-asserted-by":"publisher","first-page":"F1179","DOI":"10.1152\/ajprenal.00211.2004","volume":"287","author":"F Quentin","year":"2004","unstructured":"Quentin F, Chambrey R, Trinh-Trang-Tan MM, Fysekidis M, Cambillau M, Paillard M, et al. The Cl-\/HCO3- exchanger pendrin in the rat kidney is regulated in response to chronic alterations in chloride balance. Am J Physiol Ren Physiol. 2004;287:F1179\u20131188.","journal-title":"Am J Physiol Ren Physiol."},{"key":"710_CR16","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1172\/JCI65460","volume":"123","author":"RA Gonzalez-Villalobos","year":"2013","unstructured":"Gonzalez-Villalobos RA, Janjoulia T, Fletcher NK, Giani JF, Nguyen MT, Riquier-Brison AD, et al. The absence of intrarenal ACE protects against hypertension. J Clin Invest. 2013;123:2011\u201323.","journal-title":"J Clin Invest"},{"key":"710_CR17","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/HYPERTENSIONAHA.116.08519","volume":"69","author":"N Xu","year":"2017","unstructured":"Xu N, Hirohama D, Ishizawa K, Chang WX, Shimosawa T, Fujita T, et al. Hypokalemia and pendrin induction by aldosterone. Hypertension. 2017;69:855\u201362.","journal-title":"Hypertension."},{"key":"710_CR18","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.kint.2018.05.001","volume":"94","author":"KI Lopez-Cayuqueo","year":"2018","unstructured":"Lopez-Cayuqueo KI, Chavez-Canales M, Pillot A, Houillier P, Jayat M, Baraka-Vidot J, et al. A mouse model of pseudohypoaldosteronism type II reveals a novel mechanism of renal tubular acidosis. Kidney Int. 2018;94:514\u201323.","journal-title":"Kidney Int."},{"key":"710_CR19","doi-asserted-by":"publisher","unstructured":"Wu A, Wolley MJ, Wu Q, Gordon RD, Fenton RA, Stowasser M The Cl(-)\/HCO3(-) exchanger pendrin is downregulated during oral co-administration of exogenous mineralocorticoid and KCl in patients with primary aldosteronism. J Hum Hypertens. 2020(e-pub ahead of print 2020\/11\/12; https:\/\/doi.org\/10.1038\/s41371-020-00439-7).","DOI":"10.1038\/s41371-020-00439-7"},{"key":"710_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/MNH.0000000000000669","volume":"30","author":"S Bourgeois","year":"2021","unstructured":"Bourgeois S, Wagner CA. Regulation of renal pendrin activity by aldosterone. Curr Opin Nephrol Hypertens. 2021;30:131\u20137.","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"710_CR21","doi-asserted-by":"publisher","first-page":"F1314","DOI":"10.1152\/ajprenal.00114.2011","volume":"301","author":"JW Verlander","year":"2011","unstructured":"Verlander JW, Hong S, Pech V, Bailey JL, Agazatian D, Matthews SW, et al. Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrin. Am J Physiol Ren Physiol. 2011;301:F1314\u20131325.","journal-title":"Am J Physiol Ren Physiol."},{"key":"710_CR22","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1681\/ASN.2019080804","volume":"31","author":"N Ayuzawa","year":"2020","unstructured":"Ayuzawa N, Nishimoto M, Ueda K, Hirohama D, Kawarazaki W, Shimosawa T, et al. Two mineralocorticoid receptor-mediated mechanisms of pendrin activation in distal nephrons. J Am Soc Nephrol. 2020;31:748\u201364.","journal-title":"J Am Soc Nephrol."},{"key":"710_CR23","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.cmet.2013.10.005","volume":"18","author":"S Shibata","year":"2013","unstructured":"Shibata S, Rinehart J, Zhang J, Moeckel G, Castaneda-Bueno M, Stiegler AL, et al. Mineralocorticoid receptor phosphorylation regulates ligand binding and renal response to volume depletion and hyperkalemia. Cell Metab. 2013;18:660\u201371.","journal-title":"Cell Metab."},{"key":"710_CR24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.celrep.2018.06.072","volume":"24","author":"S Shibata","year":"2018","unstructured":"Shibata S, Ishizawa K, Wang Q, Xu N, Fujita T, Uchida S, et al. ULK1 phosphorylates and regulates mineralocorticoid receptor. Cell Rep. 2018;24:569\u201376.","journal-title":"Cell Rep."},{"key":"710_CR25","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/cge.12789","volume":"91","author":"BG Kim","year":"2017","unstructured":"Kim BG, Yoo TH, Yoo JE, Seo YJ, Jung J, Choi JY. Resistance to hypertension and high Cl(-) excretion in humans with SLC26A4 mutations. Clin Genet. 2017;91:448\u201352.","journal-title":"Clin Genet."},{"key":"710_CR26","doi-asserted-by":"publisher","first-page":"9412","DOI":"10.1016\/S0021-9258(18)48095-7","volume":"262","author":"RM Johnstone","year":"1987","unstructured":"Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262:9412\u201320.","journal-title":"J Biol Chem."},{"key":"710_CR27","doi-asserted-by":"publisher","first-page":"13368","DOI":"10.1073\/pnas.0403453101","volume":"101","author":"T Pisitkun","year":"2004","unstructured":"Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA. 2004;101:13368\u201373.","journal-title":"Proc Natl Acad Sci USA."},{"key":"710_CR28","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/sj.ki.5000273","volume":"69","author":"H Zhou","year":"2006","unstructured":"Zhou H, Yuen PS, Pisitkun T, Gonzales PA, Yasuda H, Dear JW, et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int. 2006;69:1471\u20136.","journal-title":"Kidney Int."},{"key":"710_CR29","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/ki.2009.550","volume":"77","author":"P Fernandez-Llama","year":"2010","unstructured":"Fernandez-Llama P, Khositseth S, Gonzales PA, Star RA, Pisitkun T, Knepper MA. Tamm-Horsfall protein and urinary exosome isolation. Kidney Int. 2010;77:736\u201342.","journal-title":"Kidney Int."},{"key":"710_CR30","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1038\/sj.ki.5001874","volume":"70","author":"H Zhou","year":"2006","unstructured":"Zhou H, Pisitkun T, Aponte A, Yuen PS, Hoffert JD, Yasuda H, et al. Exosomal fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int. 2006;70:1847\u201357.","journal-title":"Kidney Int"},{"key":"710_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/MNH.0000000000000192","volume":"25","author":"M Salih","year":"2016","unstructured":"Salih M, Fenton RA, Zietse R, Hoorn EJ. Urinary extracellular vesicles as markers to assess kidney sodium transport. Curr Opin Nephrol Hypertens. 2016;25:67\u201372.","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"710_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1681\/ASN.2008040406","volume":"20","author":"PA Gonzales","year":"2009","unstructured":"Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA, Kleta R, et al. Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol. 2009;20:363\u201379.","journal-title":"J Am Soc Nephrol."},{"key":"710_CR33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1681\/ASN.2014111137","volume":"27","author":"Y Qi","year":"2016","unstructured":"Qi Y, Wang X, Rose KL, MacDonald WH, Zhang B, Schey KL, et al. Activation of the endogenous renin-angiotensin-aldosterone system or aldosterone administration increases urinary exosomal sodium channel excretion. J Am Soc Nephrol. 2016;27:646\u201356.","journal-title":"J Am Soc Nephrol."},{"key":"710_CR34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00424-017-2049-0","volume":"470","author":"G Pathare","year":"2018","unstructured":"Pathare G, Dhayat N, Mohebbi N, Wagner CA, Cheval L, Neuhaus TJ, et al. Acute regulated expression of pendrin in human urinary exosomes. Pflug Arch. 2018;470:427\u201338.","journal-title":"Pflug Arch"},{"key":"710_CR35","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1172\/JCI43124","volume":"121","author":"S Shibata","year":"2011","unstructured":"Shibata S, Mu S, Kawarazaki H, Muraoka K, Ishizawa K, Yoshida S, et al. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J Clin Invest. 2011;121:3233\u201343.","journal-title":"J Clin Invest"},{"key":"710_CR36","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1073\/pnas.1817281116","volume":"116","author":"K Ishizawa","year":"2019","unstructured":"Ishizawa K, Wang Q, Li J, Yamazaki O, Tamura Y, Fujigaki Y, et al. Calcineurin dephosphorylates Kelch-like 3, reversing phosphorylation by angiotensin II and regulating renal electrolyte handling. Proc Natl Acad Sci USA. 2019;116:3155\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"710_CR37","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/ajh.2008.301","volume":"21","author":"M Feng","year":"2008","unstructured":"Feng M, Whitesall S, Zhang Y, Beibel M, D\u2019Alecy L, DiPetrillo K. Validation of volume-pressure recording tail-cuff blood pressure measurements. Am J Hypertens. 2008;21:1288\u201391.","journal-title":"Am J Hypertens"},{"key":"710_CR38","doi-asserted-by":"crossref","unstructured":"Takahasi K, Iinuma H, Wada K, Minezaki S, Kawamura S, Kainuma M, et al. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci. 2018;25:155\u201361.","DOI":"10.1002\/jhbp.524"},{"key":"710_CR39","doi-asserted-by":"publisher","first-page":"9425","DOI":"10.1073\/pnas.141241098","volume":"98","author":"F Knauf","year":"2001","unstructured":"Knauf F, Yang CL, Thomson RB, Mentone SA, Giebisch G, Aronson PS. Identification of a chloride-formate exchanger expressed on the brush border membrane of renal proximal tubule cells. Proc Natl Acad Sci USA. 2001;98:9425\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"710_CR40","doi-asserted-by":"publisher","first-page":"F1251","DOI":"10.1152\/ajprenal.00128.2014","volume":"306","author":"M Salih","year":"2014","unstructured":"Salih M, Zietse R, Hoorn EJ. Urinary extracellular vesicles and the kidney: biomarkers and beyond. Am J Physiol Ren Physiol. 2014;306:F1251\u20131259.","journal-title":"Am J Physiol Ren Physiol."},{"key":"710_CR41","doi-asserted-by":"publisher","first-page":"F560","DOI":"10.1152\/ajprenal.00242.2019","volume":"317","author":"R Sabaratnam","year":"2019","unstructured":"Sabaratnam R, Geertsen L, Skjodt K, Hojlund K, Dimke H, Lund L, et al. In human nephrectomy specimens, the kidney level of tubular transport proteins does not correlate with their abundance in urinary extracellular vesicles. Am J Physiol Ren Physiol. 2019;317:F560\u2013F571.","journal-title":"Am J Physiol Ren Physiol."},{"key":"710_CR42","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1681\/ASN.2015111221","volume":"28","author":"MJ Wolley","year":"2017","unstructured":"Wolley MJ, Wu A, Xu S, Gordon RD, Fenton RA, Stowasser M. In primary aldosteronism, mineralocorticoids influence exosomal sodium-chloride cotransporter abundance. J Am Soc Nephrol. 2017;28:56\u201363.","journal-title":"J Am Soc Nephrol."},{"key":"710_CR43","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1161\/HYPERTENSIONAHA.112.198135","volume":"60","author":"N van der Lubbe","year":"2012","unstructured":"van der Lubbe N, Jansen PM, Salih M, Fenton RA, van den Meiracker AH, Danser AH, et al. The phosphorylated sodium chloride cotransporter in urinary exosomes is superior to prostasin as a marker for aldosteronism. Hypertension. 2012;60:741\u20138.","journal-title":"Hypertension."},{"key":"710_CR44","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41440-019-0244-4","volume":"42","author":"M Satoh","year":"2019","unstructured":"Satoh M, Maruhashi T, Yoshida Y, Shibata H. Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism. Hypertens Res. 2019;42:817\u201324.","journal-title":"Hypertens Res."},{"key":"710_CR45","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.120.16429","volume":"77","author":"N Yozamp","year":"2021","unstructured":"Yozamp N, Hundemer GL, Moussa M, Underhill J, Fudim T, Sacks B, et al. Intraindividual variability of aldosterone concentrations in primary aldosteronism: implications for case detection. Hypertension. 2021;77:891\u20139.","journal-title":"Hypertension."},{"key":"710_CR46","doi-asserted-by":"publisher","first-page":"T35","DOI":"10.1530\/JOE-16-0669","volume":"234","author":"S Shibata","year":"2017","unstructured":"Shibata S. 30 years of the mineralocorticoid receptor: Mineralocorticoid receptor and NaCl transport mechanisms in the renal distal nephron. J Endocrinol. 2017;234:T35\u2013T47.","journal-title":"J Endocrinol"},{"key":"710_CR47","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nsmb.3091","volume":"22","author":"ER Geertsma","year":"2015","unstructured":"Geertsma ER, Chang YN, Shaik FR, Neldner Y, Pardon E, Steyaert J, et al. Structure of a prokaryotic fumarate transporter reveals the architecture of the SLC26 family. Nat Struct Mol Biol. 2015;22:803\u20138.","journal-title":"Nat Struct Mol Biol"},{"key":"710_CR48","first-page":"184","volume":"8","author":"AK Sharma","year":"2016","unstructured":"Sharma AK, Krieger T, Rigby AC, Zelikovic I, Alper SL. Human SLC26A4\/Pendrin STAS domain is a nucleotide-binding protein: refolding and characterization for structural studies. Biochem Biophys Rep. 2016;8:184\u201391.","journal-title":"Biochem Biophys Rep."},{"key":"710_CR49","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1007\/s00018-014-1585-4","volume":"71","author":"D Eladari","year":"2014","unstructured":"Eladari D, Chambrey R, Picard N, Hadchouel J. Electroneutral absorption of NaCl by the aldosterone-sensitive distal nephron: implication for normal electrolytes homeostasis and blood pressure regulation. Cell Mol Life Sci. 2014;71:2879\u201395.","journal-title":"Cell Mol Life Sci"},{"key":"710_CR50","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1681\/ASN.2019050551","volume":"31","author":"TD Pham","year":"2020","unstructured":"Pham TD, Verlander JW, Wang Y, Romero CA, Yue Q, Chen C, et al. Aldosterone regulates pendrin and epithelial sodium channel activity through intercalated cell mineralocorticoid receptor-dependent and -independent mechanisms over a wide range in serum potassium. J Am Soc Nephrol. 2020;31:483\u201399.","journal-title":"J Am Soc Nephrol."},{"key":"710_CR51","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0092-8674(01)00241-0","volume":"104","author":"RP Lifton","year":"2001","unstructured":"Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104:545\u201356.","journal-title":"Cell."},{"key":"710_CR52","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.115.018526","volume":"133","author":"JE Hall","year":"2016","unstructured":"Hall JE. Renal dysfunction, rather than nonrenal vascular dysfunction, mediates salt-induced hypertension. Circulation. 2016;133:894\u2013906.","journal-title":"Circulation."}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00710-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00710-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00710-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T10:03:58Z","timestamp":1675591438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00710-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["710"],"URL":"https:\/\/doi.org\/10.1038\/s41440-021-00710-5","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,29]]},"assertion":[{"value":"3 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"SS received honoraria from Daiichi Sankyo Co., Ltd., outside the current study. The company had no role in the study design, execution of experiments, decision to publish, or preparation of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}